Definitive Contract 75A50124C00039

Award Date 8/22/24
Potential Completion Date 3/31/26
Potential Value $750K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a delivery order to Emory University, a private research university located in Atlanta, Georgia, for $599,404.00. The order has a period of performance from September 14, 2020 to March 20, 2023 and is not associated with a set-aside. The order falls under the DAIT/BIOD contract vehicle. Emory University has experience providing clinical trial services, data...
This is a $245,000 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Emory University, a private research institution in Atlanta, Georgia. The contract, titled "EMORY-SARS COV2 CRYIEM," is for research and services related to the COVID-19 virus. The contract has an ultimate completion date of August 30, 2024. Emory University is a major recipient of federal contracts and grants, particularly in the areas of biomedical...
This is a firm fixed-price purchase order awarded by the National Heart Lung and Blood Institute, a component of the National Institutes of Health, to Emory University in Atlanta, Georgia. The contract, valued at $77,659.53, is for Emory University to provide research coordinator support services. The contract has an ultimate completion date of March 14, 2024. Emory University is a private research institution and a major recipient of federal contracts and grants, particularly in the areas of...
The Department of Defense's Defense Health Agency has awarded a $309,001 firm-fixed-price delivery order contract to Emory University, a private research university in Atlanta, Georgia, for clinical trial research services associated with epitrope-specific human monoclonal antibodies against Bacillus anthracis protective antigens. This contract, which has a performance period through September 2024, does not utilize any small business set-aside. Emory University, through its Office of...
This contract was awarded by the Centers for Disease Control and Prevention (CDC), which is part of the Department of Health and Human Services (HHS), to Emory University. The contract is for the delivery of ready-to-use primary human cells to characterize influenza candidate vaccine viruses (CVVs). The contract has a firm-fixed price of $178,176 and a completion date of July 15, 2022. Emory University is a private, non-profit research university with an extensive track record of performing...
This federal contract award was made by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Emory University to conduct research and development on the antiviral drug EIDD-2801. The contract has a potential value of $1,108,746.46 and runs from September 9, 2019 through July 31, 2020. The contract is a definitive contract with cost reimbursement pricing and does not have a set-aside designation. Emory University, a...
This is a delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Emory University, a private university and research institution located in Atlanta, Georgia. The contract is part of the Vaccine and Treatment Evaluation Units (VTEU) program, which focuses on the development and evaluation of vaccines and treatments for infectious diseases. The contract has a total potential value of $263,956.53 and a period of performance ending on...
This is a Delivery Order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Emory University, a private research institution in Atlanta, Georgia. The contract is part of the Vaccine and Treatment Evaluation Units (VTEU) program, which supports the development and evaluation of vaccines and treatments for infectious diseases. The Delivery Order, with a ceiling value of $4,606,034.89, covers overall...
This is a $245,000.00 firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia, to Emory University, a private non-profit research institution. The contract, titled "FLUCRYOEM," does not have a set-aside designation and is expected to be completed by August 24, 2024. Emory University, through its Office of Sponsored Programs Division, is a major recipient of federal contracts and grants, often partnering with the...
This federal contract was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency under the Department of Health and Human Services, to Emory University for $9,111.95 on a firm fixed-price basis. The contract has a period of performance through March 31, 2014. Emory University, a prestigious private research university and academic medical center located in Atlanta, Georgia, is a major recipient of federal funding and provides extensive research and...

Emory University was awarded a $749,998.20 definitive, firm-fixed price contract by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to develop "FLUVID," an innovative dry powder, inhaled, mRNA-based treatment for both influenza and COVID-19. The contract, which does not have a set-aside designation, has a performance period ending on March 31, 2026. This project showcases Emory's expertise in addressing urgent public health needs through advanced pharmaceutical research and development. Emory University has also received federal grant sub-awards, including one from Georgia State University Research Foundation Inc. to recruit participants with mild cognitive impairment or early Alzheimer's disease, and another from Ann & Robert H. Lurie Children's Hospital of Chicago to focus on a clinical trial involving allogeneic human mesenchymal stem cell injection in patients with hypoplastic left heart syndrome, demonstrating the institution's significant contributions to neurological and cardiovascular research.

Generated 2/13/25, 9:23 AM